PGI8 An Exploratory Analysis of the Survival Benefits in Commercially Insured Patients with Hepatic Encephalopathy (HE) Treated with Rifaximin versus Lactulose Alone using US Claims Data
| Autor: | M. Ahmad, M.L. Volk, George J. Joseph, Sherry Shi, Rebecca Burne, Annie Guerin, Z. Heimanson |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
business.industry Health Policy Public Health Environmental and Occupational Health Exploratory analysis medicine.disease Gastroenterology Rifaximin Lactulose chemistry.chemical_compound chemistry Internal medicine Claims data medicine business Hepatic encephalopathy medicine.drug |
| Zdroj: | Value in Health. 24:S95-S96 |
| ISSN: | 1098-3015 |
| DOI: | 10.1016/j.jval.2021.04.498 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect